MedTrace Logo

PreHospital Air Medical Plasma Trial

NCT01818427 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 523

Last updated 2021-04-08

Study results available
· View outcomes & findings →

Summary

To determine the effect of the prehospital infusion during air transport of 2 units of AB plasma on 30 day mortality in patients with hemorrhagic shock as compared to conventional care.

Conditions

  • Hemmorhagic Shock During Air Medical Transport

Interventions

BIOLOGICAL

infusion of 2 units of plasma

infusion of 2 units of plasma

Sponsors & Collaborators

  • University of Texas

    collaborator OTHER

  • University of Louisville

    collaborator OTHER

  • Vanderbilt University

    collaborator OTHER

  • Case Western Reserve University

    collaborator OTHER

  • The University of Tennessee, Knoxville

    collaborator OTHER

  • JPS Health Network

    collaborator OTHER

  • The Methodist Hospital Research Institute

    collaborator OTHER

  • Jason Sperry

    lead OTHER

Principal Investigators

  • Jason L Sperry, MD,MPH · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01818427 on ClinicalTrials.gov